AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $48,154,000 | +13.8% | 804,720 | -46.6% | 0.26% | -11.1% |
| Q3 2019 | $42,316,000 | -25.8% | 1,506,438 | 0.0% | 0.29% | -25.8% |
| Q2 2019 | $57,034,000 | -14.8% | 1,506,438 | -12.2% | 0.39% | -9.3% |
| Q1 2019 | $66,926,000 | +244.8% | 1,715,183 | +88.4% | 0.43% | +169.2% |
| Q4 2018 | $19,411,000 | +24.7% | 910,463 | +131.5% | 0.16% | +54.4% |
| Q3 2018 | $15,568,000 | +3.6% | 393,222 | 0.0% | 0.10% | -8.8% |
| Q2 2018 | $15,025,000 | +27.2% | 393,222 | 0.0% | 0.11% | +13.0% |
| Q1 2018 | $11,816,000 | – | 393,222 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 250,620 | $9,779,000 | 11.87% |
| Versant Venture Management, LLC | 803,106 | $31,337,196,000 | 10.32% |
| GREAT POINT PARTNERS LLC | 1,572,618 | $61,364,000 | 6.07% |
| Casdin Capital, LLC | 1,010,000 | $39,410,000 | 4.33% |
| Sofinnova Investments, Inc. | 933,640 | $36,431,000 | 3.51% |
| Foresite Capital Management III, LLC | 315,331 | $12,304,000 | 3.20% |
| Redmile Group, LLC | 2,735,267 | $106,730,000 | 3.12% |
| Opaleye Management Inc. | 280,000 | $10,926,000 | 3.02% |
| Global Endowment Management, LP | 391,581 | $15,279,000 | 2.16% |
| Ghost Tree Capital, LLC | 175,000 | $6,829,000 | 1.78% |